SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-18-000037
Filing Date
2018-11-01
Accepted
2018-11-01 07:33:47
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q q3201810-q.htm 10-Q 1214375
2 EXHIBIT 31.1 q32018exhibit311.htm EX-31.1 12544
3 EXHIBIT 31.2 q32018exhibit312.htm EX-31.2 12642
4 EXHIBIT 32.1 q32018exhibit321.htm EX-32.1 6835
5 EXHIBIT 32.2 q32018exhibit322.htm EX-32.2 6793
12 PIPELINE NOVEMBER 2018 pipelinenovember2018.jpg GRAPHIC 102760
  Complete submission text file 0001367920-18-000037.txt   6467484

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20180930.xml EX-101.INS 1330597
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20180930.xsd EX-101.SCH 42420
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20180930_cal.xml EX-101.CAL 74860
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20180930_def.xml EX-101.DEF 277430
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20180930_lab.xml EX-101.LAB 600240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20180930_pre.xml EX-101.PRE 392643
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 181152026
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1